Dr. Mack Roach III, MD

Dr. Roach practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Roach's NPI, 1770523359, was assigned on June 8, 2006. Dr. Roach graduated from Stanford University School Of Medicine in 1979. Dr. Roach's California license number on file is 00G42845.

Dr. Roach's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Roach's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Roach is also affiliated with Zuckerberg San Francisco General Hospital and Trauma Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Roach to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roach practices, 4 sites in all. Vendor and product names are available with a free account.

Therapeutic radiology is Dr. Roach's primary specialty in the NPI Registry, under taxonomy code 2085R0203X. Dr. Roach is board certified in internal medicine by the American Board of Internal Medicine. Dr. Roach has a license on file in California.

Dmand AI lists bladder cancer radiation, bone cancer radiation, lymphoma radiation and prostate cancer radiation among the conditions Dr. Roach treats.

CMS data shows 1,702 Medicare services from Dr. Roach across 12 procedure codes in 2024, for 153 Medicare patients. Medicare paid $159,918 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 153 Medicare patients who saw Dr. Roach in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have cancer, and 67% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Roach's median patient age at 74, with 3% women.

In 2024, Dr. Roach wrote 289 Medicare Part D claims for 87 patients. 87% of them were for generic drugs. CMS names the drug for 260 of them, across 5 drugs with 11 or more claims each, at $63,407 in total drug cost. In 2023, CMS named 299 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Roach for performance year 2024, reported as part of a group. Dr. Roach accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 226 papers to Dr. Roach, published from 2004 to 2025. 2015 was the busiest year, with 8. The most frequent topics are Prostatic Neoplasms, Prostate-Specific Antigen and Radiotherapy Dosage. Dr. Roach has published most often in Int J Radiat Oncol Biol Phys. Dr. Roach's most frequent co-authors are Howard M. Sandler, MD, I-Chow Joe Hsu, MD and Colleen A. Lawton, MD.

Dmand AI links Dr. Roach to 7 clinical trials, 3 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Neoplasm Metastasis. Radiation Therapy Oncology Group sponsors the most, 3.

CMS Open Payments shows 105 general payments to Dr. Roach from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 47% of the total. Ferring Pharmaceuticals Inc. paid the most, $38,260.

Dmand AI lists 1 award for Dr. Roach, most recently ASCO Fellow in 2010.

Dr. Roach graduated from Stanford University School Of Medicine in 1979. Dr. Roach is a member of ASCO.

Dr. Roach is in network with 4 carriers, including United Healthcare, Blue Cross and Blue Shield of Kansas City and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.